about
Elderly onset of early rheumatoid arthritis is a risk factor for bone erosions, refractory to treatment: KURAMA cohortDrug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort studyThe family history of rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-positive patient is not a predictor of poor clinical presentation and treatment response with modern classification criteria and treatment strategy: the ANSWER
P50
description
researcher (ORCID 0000-0002-7896-3937)
@en
name
Koichi Murata
@en
type
label
Koichi Murata
@en
prefLabel
Koichi Murata
@en
P31
P496
0000-0002-7896-3937